Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.13B |
| 2 |
Eaton
ETN
|
+$1.11B |
| 3 |
Analog Devices
ADI
|
+$867M |
| 4 |
Progressive
PGR
|
+$792M |
| 5 |
Datadog
DDOG
|
+$693M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.7B |
| 2 |
NVIDIA
NVDA
|
+$1.45B |
| 3 |
Salesforce
CRM
|
+$1.22B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.2B |
| 5 |
lululemon athletica
LULU
|
+$1.11B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.74% |
| 2 | Consumer Discretionary | 15.53% |
| 3 | Communication Services | 13.54% |
| 4 | Healthcare | 12.18% |
| 5 | Financials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
NMI Holdings
NMIH
$3.33B
| $1.8M | ﹤0.01% |
52,832
+1,127
| +2% | +$36.3K |
|
452
Onto Innovation
ONTO
$12.9B
| $1.75M | ﹤0.01% |
7,958
-261
| -3% | -$53.9K |
|
453
Super Micro Computer
SMCI
$18.4B
| $1.73M | ﹤0.01% |
21,150
+1,680
| +9% | +$144K |
|
|
MRNS
454
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.72M | ﹤0.01% |
1,469,285
-1,496,598
| -50% | -$3.74M |
|
455
Innoviva
INVA
$1.55B
| $1.69M | ﹤0.01% |
103,227
+25,735
| +33% | +$399K |
|
456
IQVIA
IQV
$38.7B
| $1.63M | ﹤0.01% |
7,710
-133,204
| -95% | -$30.3M |
|
|
TPH
457
DELISTED
Tri Pointe Homes
TPH
| $1.53M | ﹤0.01% |
41,066
-17,939
| -30% | -$676K |
|
458
Waste Management
WM
$90.6B
| $1.52M | ﹤0.01% |
7,122
+4,080
| +134% | +$848K |
|
|
BLD
459
DELISTED
TopBuild
BLD
| $1.5M | ﹤0.01% |
3,887
-1,295
| -25% | -$528K |
|
|
NVMI
460
Nova
NVMI
$12.4B
| $1.49M | ﹤0.01% |
6,351
-44
| -0.7% | -$8.71K |
|
461
GE Vernova
GEV
$264B
| $1.47M | ﹤0.01% |
+8,565
| New | +$1.36M |
|
462
Murphy Oil
MUR
$5.7B
| $1.43M | ﹤0.01% |
34,737
+6,862
| +25% | +$299K |
|
463
Mueller Industries
MLI
$14.7B
| $1.36M | ﹤0.01% |
47,892
+6,766
| +16% | +$190K |
|
464
Medpace
MEDP
$16.1B
| $1.35M | ﹤0.01% |
+3,285
| New | +$1.3M |
|
465
Bank of N.T. Butterfield & Son
NTB
$2.43B
| $1.34M | ﹤0.01% |
38,280
+7,740
| +25% | +$259K |
|
466
Alkermes
ALKS
$8.22B
| $1.31M | ﹤0.01% |
54,488
+9,117
| +20% | +$224K |
|
467
Norfolk Southern
NSC
$75.4B
| $1.29M | ﹤0.01% |
6,010
-131
| -2% | -$30.4K |
|
468
Rush Enterprises Class A
RUSHA
$6.2B
| $1.29M | ﹤0.01% |
30,701
+403
| +1% | +$18.5K |
|
469
Itron
ITRI
$4.36B
| $1.28M | ﹤0.01% |
12,977
+7,352
| +131% | +$740K |
|
470
iShares North American Natural Resources ETF
IGE
$741M
| $1.27M | ﹤0.01% |
28,824
+13,480
| +88% | +$605K |
|
471
Trane Technologies
TT
$100B
| $1.27M | ﹤0.01% |
3,850
| – | – |
|
472
Commercial Metals
CMC
$7.6B
| $1.22M | ﹤0.01% |
22,238
+966
| +5% | +$53.3K |
|
473
Inspire Medical Systems
INSP
$1.45B
| $1.22M | ﹤0.01% |
9,104
-248,750
| -96% | -$47.1M |
|
474
Scholar Rock
SRRK
$5.67B
| $1.17M | ﹤0.01% |
140,776
+2,318
| +2% | +$28.3K |
|
475
Matsons
MATX
$6.13B
| $1.16M | ﹤0.01% |
8,829
+116
| +1% | +$13.5K |
|
Similar funds
Jennison Associates's Q2 2024 Portfolio in Review
As of Q2 2024, Jennison Associates held 620 positions worth $156B, up 4.3% from $150B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Jennison Associates's Q2 2024 filing shows 48 new, 288 increased, 229 reduced and 48 closed positions. Its largest new stake was Analog Devices: 4,062,204 shares worth $927M. The largest sale was UnitedHealth, an estimated $1.7B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2024 buy was Analog Devices: 4,062,204 shares worth $927M.
- Jennison Associates added most to Apple in Q2 2024, an estimated $2.13B increase.
- Jennison Associates's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $1.7B.
- Jennison Associates fully exited Estee Lauder in Q2 2024, selling an estimated $291M.
- Jennison Associates's ten largest holdings make up 48% of its $156B portfolio in Q2 2024.
- Jennison Associates opened 48 new positions and closed 48 in Q2 2024.
- Jennison Associates's portfolio value rose 4.3% quarter-over-quarter to $156B.
Based on Jennison Associates's 13F filing for Q2 2024, filed 5 Aug 2024.